Portal de Periódicos da CAPES

Giardia Vaccination

2000; Elsevier BV; Volume: 16; Issue: 5 Linguagem: Inglês

10.1016/s0169-4758(99)01623-3

1873-1473

Merle S. Olson, Howard Ceri, Douglas W. Morck,

Toxoplasma gondii Research Studies

Recently, a Giardia vaccine has become commercially available in the USA for prevention of clinical signs of giardiasis and reduction of cyst shedding in dogs and cats. The vaccine is based upon the current state of knowledge of Giardia antigenicity and immunology. Here, Merle Olson, Howard Ceri and Douglas Morck describe studies that led to the development of this vaccine and subsequent efficacy studies. Immunoprophylaxis and immunotherapeutic application of the vaccine are discussed.